CSL (CSL)
Australian biotech and one of the world's largest makers of plasma-derived therapies (CSL Behring), also active in influenza vaccines (Seqirus) and iron-deficiency and nephrology treatments (Vifor).
- Legal name
- CSL Limited
- Ticker
- CSL
- Exchange
- Australian Securities Exchange · MIC XASX
- Country
- Australia
- Sector
- Healthcare
- Industry
- Plasma therapies & vaccines
- Market cap ≈
- $65bn (approx., seed-0.6 · 2026-08-29)
- Reporting currency
- AUD
- Founded
- 1916
- Website
- www.csl.com
- LEI
- 529900ECSECK5ZDQTE14 (GLEIF)
- ISIN
- AU000000CSL8 (check digit validated)
- FIGI
- BBG001S7YNK1 (share class, OpenFIGI)
Graph connections view in graph →
lists_onAustralian Securities Exchange
domiciled_inAustralia
Sector peers — Healthcare
Eli Lilly · UnitedHealth Group · Johnson & Johnson · AbbVie · Merck & Co. · Thermo Fisher Scientific
Compare: CSL vs LLY · CSL vs UNH · CSL vs JNJ
Identifier crosswalk
| Standard | Value | What it answers |
|---|---|---|
| Ticker | CSL | Venue-local shorthand — ambiguous across markets |
| MIC | XASX | ISO 10383 — the venue |
| ISIN | AU000000CSL8 | ISO 6166 — the security |
| LEI | 529900ECSECK5ZDQTE14 | ISO 17442 — the legal entity |
| FIGI | BBG001S7YNK1 | OpenFIGI — instrument, share class |
One entity, six naming systems. Each linked code opens its reverse-lookup page; the validator checks any code's check digit. CUSIP is shown because it is embedded in US/CA ISINs — we verify it, we do not redistribute CUSIP data.
Approximate reference values from public sources · seed-0.6 · 2026-08-29 · not real-time. See data & methodology.